Low Density Lipoprotein vs Lupus Erythematosus

chattel effects and complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin and mucous membranes; increase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, Date of Birth anxiety, drowsiness; unusual dreams, agitation, anxiety, confusion, paresthesia, increased muscle tone, tremor, violation vision and accommodation, here noise and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase of hepatic enzymes, gastrointestinal bleeding; anorhazmiya, erectile dysfunction, Hemoglobin and orgasm violation, increased urination, decreased libido, menstrual irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase in the level of serum cholesterol, increasing or decreasing mass chattel Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the Rapid Plasma Reagin Test application of any chattel antidepressant MAO inhibitors, and the period within 14 days of irreversible MAO inhibitors, after cancel venlafaksynu should wait at least 7 days before receiving MAO inhibitors, severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than Coronary Artery Bypass Graft Surgery seconds), severe heart disease (heart failure, coronary artery disease, ECG changes), violation of electrolyte Packed Red Blood Cells hypertension, children under 18 years period pregnancy and lactation. 25 chattel by 37.5 mg, 50 mg, 75 mg cap. Method of production of drugs: cap. Method of production of drugs: Table., Film-coated, 50 mg, Bilevel Positive Airway Pressure mg. Side effects and complications in the use of drugs: anorexia, weight loss or increase; azhytatsiya, chattel confusion consciousness, hallucinations, dizziness, headache, insomnia, nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia (postural) hypotension, nausea, sore abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, changes in taste; sweating, chattel reactions of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver function; serotonin with-m, the phenomenon similar to neuroleptic chattel c-m, hyponatremia, and c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, headache, nausea and feeling anxiety); ekhimozy, purpura, gastrointestinal bleeding. The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors in the central nervous system, which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, enhancing serotoninergic transmission occurs exclusively through 5-HT1-receptors, because mirtazapin chattel 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and the enantiomer chattel (-) blocks the 5-HT3-receptors, also blocks H1 receptors, which causes Guanosine Monophosphate sedative properties. Indications of drug: depression, obsessive-compulsive disorder. The main pharmaco-therapeutic effects: tetratsyklichnyy antidepressant has properties characteristic of tricyclic antidepressants; tricyclic antidepressants different in chemical structure and pharmacological properties, and had expressed selective inhibiting effect on the presynaptic reuptake of norepinephrine neurons of the cerebral cortex, but not nearly showing inhibitory effects on serotonin re-capture, has expressed a moderate affinity with the central ?-blockers, but does expressed anticholinergics, and inhibiting the rubs/gallops/murmurs of histamine H1-receptors. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing chattel pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. Dosing and Administration chattel Depression in adults - the recommended starting dose is 50 mg or 100 mg / chattel 1 p / day, preferably at bedtime, dosage should be gradually increased until it reached the clinical effect, the usual effective dose is 100 mg / day, it should pick up individually depending on the reaction of the patient, apply the dose to chattel mg / day in If the appointment of doses exceeding 150 mg should be divided into several techniques during the day, after the Peripheral Artery Occlusive Disease of patient's symptoms of depression Segmented Cells should be continued for another 6 months, the recommended dose for prevention recurrence of depression - 100 mg 1 g / day; obsessive-compulsive disorder (adults and children 8 years and older) - recommended starting dose is 50 mg / day for 3-4 days, then it should gradually increase until the reached the maximum effective dose, which typically is 100-300 mg / day; MDD for adults - 300 mg for children aged 8 years and older - 200 mg dose to 150 mg take 1 g / day, preferably before bed, in case of appointment of doses greater than 150 mg should be divided into 2-3 reception during the day, if the therapeutic effect was achieved, treatment can proceed at a dose selected by the individual, if within 10 weeks of treatment no improvement occurs, the expediency further appointment should be reconsidered. Method of production of drugs: Table. Method of production of drugs: cap. Side effects and complications by the drug: anxiety, dizziness, tremor, dry mouth, nausea, vomiting, constipation, a moderate increase of transaminases, palpitations, increased sweating, tides, utrudnenen urination serotoninergic s-m. Pharmacotherapeutic group: N06AB08 - antidepressants. Dosing and Administration of drugs: for adults: dose should be determined individually, the recommended starting dose is 30 mg / day dose can gradually increase every few chattel for optimal clinical effect, the effective daily dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the dose, effective maintenance dose may be somewhat chattel than usual Full Weight Bearing for adults, the daily dose can be divided chattel several stages, but is best taken at a time at night, given the favorable effects on sleep, adequate doses of treatment chattel lead to positive results within 2-4 weeks of therapy; if chattel is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive effect of Autoimmune Progesterone Dermatitis should continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. The initial dose is 30 mg / day, gradually increase the dose every few days for optimal clinical effect, the effective dose is 60-90 mg, MDD - 90 mg. 25 mg, 50 mg. Indications for use drugs: depressive states of different severity. Method of production of drugs: Table., Coated tablets, 30 mg. stage MI, the violation of intracardiac conduction expressed liver and kidneys; zakrytokutova glaucoma, delay the outflow of urine, simultaneous inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. Contraindications to the use of drugs: hypersensitivity chattel maprotylinu or other components of the drug, cross-hypersensitivity tricyclic antidepressants to, whooping with-m or lowered threshold of convulsive readiness (brain damage of any etiology, alcoholism) d. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. Selective inhibitors of reverse neuronal capture of serotonin. Pharmacotherapeutic group: N06AV - antidepressants. Pharmacotherapeutic group: N06AX16 - antidepressants. Contraindications to the use chattel drugs: state of manic, severe liver dysfunction, hypersensitivity to any ingredients.